CN102004103B - Kit for the detection of tyrosine-like phenolic metabolites in human urine - Google Patents
Kit for the detection of tyrosine-like phenolic metabolites in human urine Download PDFInfo
- Publication number
- CN102004103B CN102004103B CN2010105057934A CN201010505793A CN102004103B CN 102004103 B CN102004103 B CN 102004103B CN 2010105057934 A CN2010105057934 A CN 2010105057934A CN 201010505793 A CN201010505793 A CN 201010505793A CN 102004103 B CN102004103 B CN 102004103B
- Authority
- CN
- China
- Prior art keywords
- nitrate solution
- mercury
- solution
- kit
- mercuric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
一种用于检测人体尿液中酪氨酸类酚代谢物的试剂盒,包括试剂,试剂由0.1-0.2g/ml的硫酸汞溶液、1-2g/ml的硝酸汞溶液、0.1-0.2g/ml的硝酸镍溶液按体积比,即硝酸汞溶液∶硫酸汞溶液∶硝酸镍溶液=1∶0.5~1.5∶0.5~2,混合而成,为淡绿色透明液体。本发明的试剂盒,是在Millon试剂原理基础上进行创新,它排除了尿液中碱性物质、金属离子和其他相关物质对试剂检测的干扰,提高了检测的灵敏度和准确性。A kit for detecting tyrosine phenolic metabolites in human urine, comprising reagents, the reagents are 0.1-0.2g/ml mercury sulfate solution, 1-2g/ml mercury nitrate solution, 0.1-0.2g The nickel nitrate solution per ml is mixed by volume, i.e. mercuric nitrate solution: mercuric sulfate solution: nickel nitrate solution=1: 0.5~1.5: 0.5~2, and is a light green transparent liquid. The kit of the present invention is innovated on the basis of the principle of Millon reagent, which eliminates the interference of alkaline substances, metal ions and other related substances in urine on reagent detection, and improves the sensitivity and accuracy of detection.
Description
技术领域 technical field
本发明涉及一种用于检测人体尿液中酪氨酸类酚代谢物的试剂盒。The invention relates to a kit for detecting tyrosine phenolic metabolites in human urine.
技术背景 technical background
早期发现是治疗肿瘤的关键,肿瘤的发展分为五个阶段:良性、肿瘤细胞启动期、肿瘤早期、肿瘤中期、晚期。癌症的可怕之处,就在于前三个阶段,影像学根本无法检测出来,即便到了肿瘤中期,也只有非常专业的医生用较先进的设备才能测出。世界卫生组织的研究认为:目前1/3的癌症是可以预防的;1/3的癌症可以通过积极治疗而延长患者生命;1/3的癌症是可以通过早期发现、早期诊断、早期治疗而痊愈的。癌症病人的尿液中特征氨基酸代谢异常,产生大量的酪氨酸类酚代谢物。检测酪氨酸类酚代谢物的含量,可以推断人体是否患有癌症。Early detection is the key to the treatment of tumors. The development of tumors is divided into five stages: benign, tumor cell initiation, early tumor, mid-tumor, and late stage. The frightening thing about cancer is that the first three stages cannot be detected by imaging. Even in the middle stage of the tumor, only very professional doctors can detect it with advanced equipment. According to the research of the World Health Organization: 1/3 of cancers can be prevented at present; 1/3 of cancers can prolong the life of patients through active treatment; 1/3 of cancers can be cured through early detection, early diagnosis and early treatment of. The abnormal amino acid metabolism in the urine of cancer patients produces a large number of tyrosine-like phenolic metabolites. Whether the human body suffers from cancer can be deduced by detecting the content of tyrosine phenolic metabolites.
发明内容 Contents of the invention
本发明的目的就是提供一种检测灵敏度高、准确性好的用于检测人体尿液中酪氨酸类酚代谢物的试剂盒。The object of the present invention is to provide a kit for detecting tyrosine-like phenolic metabolites in human urine with high detection sensitivity and good accuracy.
本发明的用于检测人体尿液中酪氨酸类酚代谢物的试剂盒,包括试剂,试剂由0.1-0.2g/ml的硫酸汞溶液、1-2g/ml的硝酸汞溶液、0.1-0.2g/ml的硝酸镍溶液按体积比,即硝酸汞溶液∶硫酸汞溶液∶硝酸镍溶液=1∶0.5~1.5∶0.5~2,混合而成,为淡绿色透明液体。The kit for detecting tyrosine phenolic metabolites in human urine of the present invention includes reagents, the reagents are mercuric sulfate solution of 0.1-0.2 g/ml, mercuric nitrate solution of 1-2 g/ml, mercuric nitrate solution of 0.1-0.2 The nickel nitrate solution of g/ml is mixed according to the volume ratio, that is, mercury nitrate solution: mercury sulfate solution: nickel nitrate solution=1: 0.5~1.5: 0.5~2, and is a light green transparent liquid.
试剂中各组份的配制方法:0.1-0.2g/ml的硫酸汞溶液按浓度计算,准确称取硫酸汞(分析纯)试剂的量,溶解于3mol/L的硫酸溶液中,配制成该浓度的硫酸汞溶液;1-2g/ml的硝酸汞溶液用20g汞与比重为1.4的硝酸30ml的比例进行反应,待汞完全溶解后,加入1-2倍于该反应产物体积的蒸馏水,配制成该浓度的硝酸汞溶液;0.1-0.2g/ml的硝酸镍溶液按浓度计算,准确称取硝酸镍(分析纯)试剂的量,溶解于蒸馏水中,配制成该浓度的硝酸镍溶液。The preparation method of each component in the reagent: 0.1-0.2g/ml mercury sulfate solution is calculated according to the concentration, accurately weigh the amount of mercury sulfate (analytical pure) reagent, dissolve it in 3mol/L sulfuric acid solution, and prepare the concentration Mercury sulfate solution; 1-2g/ml mercury nitrate solution is reacted with 20g mercury and 30ml nitric acid whose specific gravity is 1.4. After the mercury is completely dissolved, add distilled water 1-2 times the volume of the reaction product to prepare The mercury nitrate solution of this concentration; the nickel nitrate solution of 0.1-0.2g/ml is calculated according to the concentration, accurately takes by weighing the amount of nickel nitrate (analytical pure) reagent, is dissolved in distilled water, is mixed with the nickel nitrate solution of this concentration.
本发明的用于检测人体尿液中酪氨酸类酚代谢物的试剂盒,检测方法:取被检者尿液3ml,滴加到装有本试剂0.5ml的试管中,静置2-5分钟,发生沉淀和颜色反应,根据沉淀的有无和沉淀的颜色判断。The test kit for detecting tyrosine-like phenolic metabolites in human urine of the present invention, the detection method: take 3ml of the subject's urine, add it dropwise to a test tube containing 0.5ml of this reagent, and let it stand for 2-5 Minutes, precipitation and color reaction occur, judge according to the presence or absence of precipitation and the color of precipitation.
判断标准:1、若反应无沉淀,或有沉淀,颜色为白色或黄色,判断为阴性,提示体内没有癌症;2、若反应有沉淀,颜色为玫瑰红或砖红,判断为阳性,提示体内有癌症。Judgment criteria: 1. If there is no precipitation in the reaction, or if there is precipitation, the color is white or yellow, it is judged as negative, indicating that there is no cancer in the body; 2. If the reaction has precipitation, the color is rose red or brick red, it is judged as positive, indicating that there is no cancer in the body. have cancer.
医学及临床研究表明,癌细胞的高繁殖率和高代谢率使癌症患者尿液出现大量的含酚核的氨基酸(酪氨酸)代谢物,而正常人尿液中不出现或仅含极低浓度的此类氨基酸代谢物,因此,酪氨酸类酚代谢物成为肿瘤标志物之一。本试剂中的汞盐与此肿瘤标志物特异性反应,反应产物经分子异构和氧化生成红色沉淀物,而与正常人尿液反应无沉淀或沉淀物为黄色,通过沉淀物及其颜色来判断此类肿瘤标志物的存在与否,进而推断是否携带癌细胞,即是否为癌症患者。Medical and clinical studies have shown that the high reproduction rate and high metabolic rate of cancer cells cause a large number of amino acid (tyrosine) metabolites containing phenolic nucleus to appear in the urine of cancer patients, while normal people's urine does not appear or only contains very low Concentration of such amino acid metabolites, therefore, tyrosine phenolic metabolites become one of the tumor markers. The mercury salt in this reagent reacts specifically with this tumor marker, and the reaction product generates a red precipitate through molecular isomerization and oxidation, but it reacts with normal human urine without precipitation or the precipitate is yellow, which can be identified by the precipitate and its color Determine the presence or absence of such tumor markers, and then infer whether they carry cancer cells, that is, whether they are cancer patients.
本发明的用于检测人体尿液中酪氨酸类酚代谢物的试剂盒,是在Millon试剂原理基础上进行创新,它排除了尿液中碱性物质、金属离子和其他相关物质对试剂检测的干扰,提高了检测的灵敏度和准确性,经肿瘤医院的临床验证,300例均为经组织学确诊的癌症病人中检出278例为阳性患者,准确率(符合率)达到92.6%。The kit for detecting tyrosine-like phenolic metabolites in human urine of the present invention is an innovation based on the principle of Millon reagent, which eliminates the detection of alkaline substances, metal ions and other related substances in urine. According to the clinical verification of the Cancer Hospital, 278 of the 300 cases of cancer patients diagnosed by histology were positive, and the accuracy rate (coincidence rate) reached 92.6%.
具体实施方式 Detailed ways
一种用于检测人体尿液中酪氨酸类酚代谢物的试剂盒,配制本试剂盒1000ml的试剂方法:A kit for detecting tyrosine-like phenolic metabolites in human urine, the reagent method for preparing 1000ml of the kit:
试剂由三种溶液组成,按体积比例,即硝酸汞溶液∶硫酸汞溶液∶硝酸镍溶液=1∶1∶2,分别配制为250ml,250ml和500ml,将三种溶液混合均匀即配制成1000ml本试剂。The reagent is composed of three kinds of solutions, according to the volume ratio, that is, mercury nitrate solution: mercury sulfate solution: nickel nitrate solution = 1:1:2, respectively prepared as 250ml, 250ml and 500ml, and the three solutions are mixed evenly to prepare 1000ml. reagent.
各组份的配制方法如下:The preparation method of each component is as follows:
1、硝酸汞溶液浓度为1g/ml,称取64g汞溶解于比重1.4的硝酸96ml中,待汞完全溶解,加入166.7ml的蒸馏水,即配制成250ml,浓度为1g/ml的硝酸汞溶液;1. The concentration of mercury nitrate solution is 1g/ml. Weigh 64g of mercury and dissolve it in 96ml of nitric acid with a specific gravity of 1.4. After the mercury is completely dissolved, add 166.7ml of distilled water to prepare 250ml of mercury nitrate solution with a concentration of 1g/ml;
2、硫酸汞溶液浓度为0.1g/ml,称取25g硫酸汞试剂,溶解于少量的3mol/L的硫酸溶液中,再加入3mol/L的硫酸溶液至250ml,即配制成浓度为0.1g/ml的硫酸汞溶液;2. The concentration of mercuric sulfate solution is 0.1g/ml. Weigh 25g of mercuric sulfate reagent, dissolve it in a small amount of 3mol/L sulfuric acid solution, and then add 3mol/L sulfuric acid solution to 250ml to prepare a concentration of 0.1g/ml. ml of mercury sulfate solution;
3、硝酸镍溶液浓度为0.1g/ml,称取6水硝酸镍80g,溶解于少量蒸馏水中,再加入蒸馏水至500ml,即配制成浓度为0.1g/ml的硝酸镍溶液。3. The concentration of nickel nitrate solution is 0.1g/ml. Weigh 80g of nickel nitrate hexahydrate, dissolve it in a small amount of distilled water, and then add distilled water to 500ml to prepare a nickel nitrate solution with a concentration of 0.1g/ml.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105057934A CN102004103B (en) | 2010-10-13 | 2010-10-13 | Kit for the detection of tyrosine-like phenolic metabolites in human urine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105057934A CN102004103B (en) | 2010-10-13 | 2010-10-13 | Kit for the detection of tyrosine-like phenolic metabolites in human urine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102004103A CN102004103A (en) | 2011-04-06 |
CN102004103B true CN102004103B (en) | 2012-02-29 |
Family
ID=43811649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105057934A Active CN102004103B (en) | 2010-10-13 | 2010-10-13 | Kit for the detection of tyrosine-like phenolic metabolites in human urine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102004103B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10234397B2 (en) * | 2014-12-25 | 2019-03-19 | Jiangsu Dongbo Bio-Pharmaceutical Co. Ltd. | Monohydroxyphenyl metabolite urine detection reagent and preparation method thereof |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102565055B (en) * | 2012-01-16 | 2013-10-30 | 李德海 | Preparation method for urine monohydroxyphenyl metabolites detection reagent |
CN103323452B (en) * | 2013-06-21 | 2014-07-09 | 吉林生物研究院有限公司 | P-hydroxy phenylalanine urine detection reagent and preparation method thereof |
CN104390974B (en) * | 2014-10-31 | 2016-03-02 | 江苏东博生物医药有限公司 | In a kind of urine, tumor markers tryptophane detects reagent and preparation method |
CN104390975B (en) * | 2014-10-31 | 2016-03-02 | 江苏东博生物医药有限公司 | In urine, tumor markers 5-hydroxyindoleacetic acid detects reagent and preparation method |
US10845361B2 (en) | 2015-02-05 | 2020-11-24 | Ath (Australia) Pty Ltd | Formulations comprising mercury-containing reagents for detecting disease |
CN104949967B (en) * | 2015-06-09 | 2016-08-24 | 杭州欣叶生物科技有限公司 | The kit of tyrosine phenol metabolism thing in detection human urine |
CN105044100A (en) * | 2015-07-28 | 2015-11-11 | 杭州欣叶生物科技有限公司 | Kit for detecting tyrosine phenolic metabolite in human urine |
CN105181687A (en) * | 2015-08-28 | 2015-12-23 | 朱建华 | Hydroxyl phenylalanine tyrosine urine detecting kit |
CN105136793A (en) * | 2015-09-21 | 2015-12-09 | 苏州锐霖生物科技有限公司 | Preparation method of reagent for detecting hydroxyl phenylalanine metabolite from urine |
CN105203537A (en) * | 2015-09-23 | 2015-12-30 | 杭州欣叶生物科技有限公司 | Urine testing reagent for tyrosine phenol metabolin |
CN105527284A (en) * | 2015-12-21 | 2016-04-27 | 北京北斗星航生物科技有限公司 | Reagent for detecting tyrosine tumor markers in human urine |
CN105628692A (en) * | 2015-12-22 | 2016-06-01 | 大连一科生物科技有限公司 | Reagent for rapidly detecting small molecular phenol component in urine and preparation technology |
CN105866113A (en) * | 2016-04-18 | 2016-08-17 | 杨祖平 | Preparation method of urinalysis reagent kit with phenol nucleus amino acid and derivative thereof |
CN106093033A (en) * | 2016-06-15 | 2016-11-09 | 江西格朗生物技术有限公司 | The preparation method of broad-spectrum tumor urinalysis reagent |
CN106226299A (en) * | 2016-08-15 | 2016-12-14 | 李永福 | For detecting the test kit of tyrosine phenol metabolism thing |
CN107064482B (en) * | 2017-04-26 | 2019-03-08 | 上海菲济生物科技有限公司 | A kind of list hydroxyl phenolic metabolism object human urine detection reagent |
CN107084977B (en) * | 2017-04-26 | 2020-02-18 | 浙江欣叶健康管理有限公司 | Reagent for detecting tyrosine phenol metabolites in urine and product thereof |
CN109115764B (en) * | 2018-07-30 | 2021-06-15 | 深圳瑞达生物股份有限公司 | Environment-friendly urine hydroxybenzene derivative detection reagent and preparation method thereof |
CN109406502B (en) * | 2018-10-22 | 2021-01-26 | 南京邮电大学 | A detection reagent for phenolic amino acid solution |
CN109470696A (en) * | 2018-12-27 | 2019-03-15 | 冀晓玲 | A kind of detection reagent and preparation method thereof of quick detection urine para hydroxybenzene alanine |
CN109682807B (en) * | 2019-03-06 | 2021-09-21 | 武汉福朗科技发展有限公司 | Monohydroxyphenol urinalysis kit capable of resisting interference of urine components, and preparation method, operation method and application thereof |
CN112213304A (en) * | 2020-10-16 | 2021-01-12 | 深圳市宸果材料科技有限公司 | Urine sieve cancer kit based on color comparison |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0341803A1 (en) * | 1988-03-11 | 1989-11-15 | SAM I1 PHARMACEUTICAL MANUFACTURING CO., Ltd | Improved Millon's reagent for cancer screening diagnosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1053043C (en) * | 1996-08-16 | 2000-05-31 | 施瑞生物技术(深圳)有限公司 | Fast urine testing reagent for cancer |
-
2010
- 2010-10-13 CN CN2010105057934A patent/CN102004103B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0341803A1 (en) * | 1988-03-11 | 1989-11-15 | SAM I1 PHARMACEUTICAL MANUFACTURING CO., Ltd | Improved Millon's reagent for cancer screening diagnosis |
Non-Patent Citations (1)
Title |
---|
Manki Park,et al..Development of Reagent for Cancer Diagnosis by Urine Color Reaction (D-Comparative analysis of cancer and non-cancer urine by NMR, HPLC and Gift reagent.《Arch. Pharm. Res.》.1988,第11卷(第2期),134-138. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10234397B2 (en) * | 2014-12-25 | 2019-03-19 | Jiangsu Dongbo Bio-Pharmaceutical Co. Ltd. | Monohydroxyphenyl metabolite urine detection reagent and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102004103A (en) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102004103B (en) | Kit for the detection of tyrosine-like phenolic metabolites in human urine | |
CN104535565B (en) | Single hydroxyl phenolic metabolism thing urine detection reagent and preparation method thereof | |
CN103323452B (en) | P-hydroxy phenylalanine urine detection reagent and preparation method thereof | |
CN102565055B (en) | Preparation method for urine monohydroxyphenyl metabolites detection reagent | |
WO2016066054A1 (en) | Detection reagent for tumour marker 5-hydroxyindoleacetic acid in urine, and preparation method | |
CN104390974B (en) | In a kind of urine, tumor markers tryptophane detects reagent and preparation method | |
CN105784831A (en) | Method for detecting trace elements in human body whole blood through inductively coupled plasma mass spectrometry method | |
CN103512880B (en) | Joint detection kit for sialic acid and hydroxyproline | |
JPH02167475A (en) | Reagent for cancer diagnosis and | |
CN104483472A (en) | Diagnostic reagent for cervical cancer cell detection and preparation method thereof | |
CN101713740B (en) | Method for spectrophotometrically measuring boron content in BNCT medicine in biological samples | |
CN104698160B (en) | A kind of test kit for assessing male's twenty-four-hour urine sodium value | |
CN104406975A (en) | Method for preparing detection reagent of para hydroxyl phenylalanine in urea | |
CN105527284A (en) | Reagent for detecting tyrosine tumor markers in human urine | |
CN105181687A (en) | Hydroxyl phenylalanine tyrosine urine detecting kit | |
CN105866113A (en) | Preparation method of urinalysis reagent kit with phenol nucleus amino acid and derivative thereof | |
CN104597046A (en) | Cancer urine detection reagent | |
Kang et al. | Ratiometric upconversion luminescence sensing platform for visual monitoring of antiarrhythmic drug level in serum | |
CN117169320A (en) | Blood multi-metal ion combination for colorectal cancer diagnosis and application thereof | |
CN105203537A (en) | Urine testing reagent for tyrosine phenol metabolin | |
CN104655624A (en) | Preparation method of reagent for detecting monohydroxyphenyl metabolites in human saliva | |
CN109212013A (en) | Based on ICP-MS detection pregnant woman's lead, cadmium mixing exposure as the auxiliary diagnosis marker of premature labor and its application | |
CN105461605B (en) | A kind of compound for cancer detection | |
CN103901029B (en) | A kind of oxidative damage external detection method and detection kit | |
CN107084977A (en) | The detection reagent and its product of tyrosine phenolic metabolism thing in urine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGXI HUAYUKANG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHU JIANHUA Effective date: 20131120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 330039 NANCHANG, JIANGXI PROVINCE TO: 330096 NANCHANG, JIANGXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131120 Address after: 330096, No. four, West 555, hi tech Avenue, Nanchang hi tech Zone, Jiangxi Patentee after: JIANGXI HUAYUKANG BIOTECHNOLOGY CO., LTD. Address before: 330039 Nanchang City, Jiangxi Province, Qingshan District, Jiangsu Province, Huayuan Road HUAYU Jiangxi Biological Technology Co., Ltd. Patentee before: Zhu Jianhua |